The hard part is already done: the expensive phase of a major undertaking is finished, and the company is now in the col
The model's full reasoning — Q2 2021 call → NOWe need to evaluate if management conveys that they have recently finished the expensive, uncertain, or heavy phase of a major undertaking and have now entered the collecting phase, with reported results still reflecting the paying phase rather than the collecting phase. Look for clues in the transcript. Key topics: Alsid acquisition (closed late April 2021). They mention "two months of incremental expense from Alsid" and "de minimis revenue contribution, including the write down of the acquired deferred revenue." That suggests integration costs and revenue deferral. But is that a "major undertaking" that is now complete? They say "our Alsid acquisition closed only recently in late April" and they are integrating. They also mention "we are aggressively growing pipeline" for Tenable.ad, and "we expect Tenable.ad sales to play out along longer enterprise sales cycles." So the heavy phase of integration might be done? But they don't explicitly say the build is done. They are still investing. Another possible undertaking: Tenable.ep launched in February 2021. They say "we launched it in the end of February" and now they have "full quarter under our belt" and are pleased with success. That is a product launch. Are they past the heavy phase? They are still investing in sales and marketing, adding quota. They say "we expect to continue to add quota capacity in the second half of the year." So not done. What about the shift to cloud? They say "IO has grown faster than SC for several quarters in a row, which we expect to continue." That's ongoing. Is there any specific statement that a heavy phase is substantially complete? Perhaps the Alsid acquisition integration? They say "we've been hard at work on integrating the businesses, creating enablement programs... and building pipeline." But not that it's done. They say "the addition of our identity and user permission vulnerability assessment to our cyber exposure platform was well received" but that's a product. Also they mention "We also recently completed a debt issuance in July" - that's financial, not an undertaking. Look for language like "behind us", "completed", "finished", "peaked". I see "we've continued to build on the strong momentum" but not a completion.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| CURV | Torrid Holdings Inc. | Q2 2022 | 2022-09-07 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| HTLF | Heartland Financial USA, Inc. | Q3 2017 | 2017-10-30 | B+ |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| ARCB | ArcBest Corporation | Q4 2016 | 2017-02-08 | C |
IONS · Q1 2017 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the heavy phase of the SPINRAZA program as concluded ("we concluded our costly Phase III program"), with R&D expenses now expected to decline as the company transitions to a multiproduct profitable organization. They note that Q1 marked the first full quarter of commercial revenues ($47 million), with royalties of 5.2 million reflecting the early stage of this new revenue stream, while the reported results still include substantial R&D revenue (102 million) and show profitability driven by the ongoing evolution toward sustained profitability. The commercial benefits are visibly beginning but remain early, with the numbers carrying the burden of the prior development effort.
PKOH · Q3 2022 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the phase where they collect...YES Management describes the restructuring of 14 global locations as "largely completed," with the cycle finished and no significant customer attrition. They are now pivoting to focus on the balance sheet and "harvesting some of the significant cash investments" made over the last couple of years, while noting that earnings are continuing to improve sequentially in Q4 despite inflation. The reported results show positive cash flow and improved metrics, but the harvest is described as beginning, with the $60 million working capital investment expected to convert over 12-18 months, indicating the collecting phase is early and the numbers still largely reflect the prior paying phase.
AKYA · Q2 2023 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the first phase (2021–end of 2022) as having completed its core objectives: successful launch of Fusion, portfolio development, organizational expansion, and platform enhancements. They explicitly frame the second phase as now beginning, with the reported Q2 results still carrying the burden of that prior heavy investment (high OpEx, RIF charges, gross-margin pressure) while the new phase is visibly starting to deliver through record revenue, reagent pull-through, and cost-optimization moves. The numbers lag the crossing, as the company is still pre-profitability and targeting cash-flow positivity only in 2025.